MIL-OSI Europe: Written question – Infection prevention and action against antimicrobial resistance, including innovative therapies – E-000213/2025

Question for written answer  E-000213/2025
to the Commission
Rule 144
András Tivadar Kulja (PPE)

In September 2024, Member State leaders and global counterparts committed, under the UN’s Political Declaration on antimicrobial resistance (AMR), to reduce the estimated 4.95 million deaths associated with bacterial AMR by 10 % by 2030.

Considering the outlined need for ‘stepping up’ efforts on preventive health and advancing work on AMR in collaboration with Member States, as stated in the mission letter addressed to the new Commissioner for Health and Animal Welfare:

• 1.How will infection prevention efforts beyond traditional water, sanitation and hygiene (WASH) and vaccination programmes specifically addressing AMR be integrated into the Commission’s broader preventive health agenda, and what binding legislative actions is the Commission planning to adopt to ensure the EU meets the UN’s 2030 target for reducing deaths associated with AMR?
• 2.How does the Commission plan to enhance research efforts and conduct impact assessment campaigns on innovative AMR therapies, such as bacteriophages, antimicrobial peptides, gene editing technologies and modern probiotics to ensure faster and equitable access to the most effective treatments across Europe?
• 3.What measures will the Commission implement to strengthen the monitoring and reporting of antimicrobial use in animal welfare, ensuring alignment with the EU’s AMR reduction targets?

Submitted: 20.1.2025